Summary
This review seeks to explain three features of viral respiratory illnesses that have perplexed generations of virologists: (1) the seasonal timing of respiratory illness and the rapid response of outbreaks to weather, specifically temperature; (2) the common viruses causing respiratory illness worldwide, including year‐round disease in the Tropics; (3) the rapid arrival and termination of epidemics caused by influenza and other viruses. The inadequacy of the popular explanations of seasonality is discussed, and a simple hypothesis is proposed, called temperature dependent viral tropism (TDVT), that is compatible with the above features of respiratory illness. TDVT notes that viruses can spread more effectively if they moderate their pathogenicity (thereby maintaining host mobility) and suggests that endemic respiratory viruses accomplish this by developing thermal sensitivity within a range that supports organ‐specific viral tropism within the human body, whereby they replicate most rapidly at temperatures below body temperature. This can confine them to the upper respiratory tract and allow them to avoid infecting the lungs, heart, gut etc. Biochemical and tissue‐culture studies show that ‘wild’ respiratory viruses show such natural thermal sensitivity. The typical early autumn surge of colds and the occurrence of respiratory illness in the Tropics year‐round at intermediate levels are explained by the tendency for strains to adapt their thermal sensitivity to their local climate and season. TDVT has important practical implications for preventing and treating respiratory illness including Covid‐19. It is testable with many options for experiments to increase our understanding of viral seasonality and pathogenicity.
Keywords: Covid‐19, influenza, pathogenicity, seasonality, SARS‐CoV‐2, temperature sensitivity, viral respiratory illness
Abbreviations
- TDVT
temperature dependent viral tropism
- ts
thermally sensitive
1. DEFINITION OF TERMS
In this review, ‘dormant’ means biochemically inactive, or active at low levels. It may imply no viral replication, or low levels of replication. As discussed below, dormant virions may be invisible to the host immune system. (The word ‘latent’ is avoided because this refers to retroviruses and herpesviruses whose genomes persist within the host, from which they can subsequently reactivate, which are not considered here.) The locations of dormant viruses in the respiratory tract (in, on or between cells) is unknown, and may vary.
A ‘mild’, ‘attenuated’ or ‘less pathogenic’ respiratory virus is one that is more thermally sensitive (ts). Such viruses possess biochemistry that is most active at temperatures below normal body temperature. A ‘virulent’ or ‘highly pathogenic’ virus is one that is less ts, or active at both body temperature and below. A highly pathogenic virus is likely to cause respiratory illness at any ambient temperature. A mild respiratory virus is likely to cause respiratory illness only at low ambient temperature. For a mild respiratory virus, the ‘permissive’ temperature is the temperature of the nose and throat, while the temperature of the lungs is ‘restrictive’. For a highly pathogenic virus the temperature of all parts of the body is permissive.
2. INTRODUCTION: CONVENTIONAL EXPLANATIONS OF THE SEASONALITY OF VIRAL ILLNESS, AND THEIR PROBLEMS
Scientists have for decades recognised the tendency of viral illnesses to worsen during predictable seasons. 1 , 2 This review focuses on four features of the respiratory viral illness seasonality that lack rigorous and convincing scientific explanations:
Seasonal timing and weather influence.
Common viruses worldwide.
Rapid arrival and termination.
2.1. Seasonal timing and weather influence
The seasonal occurrence of viral respiratory illness in temperate regions, with more illness during colder seasons (Figure 1), including a surge in respiratory illness that frequently appears in early autumn (Figure 2), demands scientific explanation. The shared winter seasonality of so many unrelated viral species is extraordinary. 3 , 4 The diverse characteristics of some important human respiratory viruses that cause illness with winter seasonality are shown in Table 1.
TABLE 1.
Family | Viruses causing human respiratory illness | Primary genetic material | Replication site in the cell | Presence of lipid envelope | Virion shape |
---|---|---|---|---|---|
Adenoviridae | Adenovirus | Double‐stranded DNA | Nucleus | No envelope | Icosahedral |
Coronaviridae | Coronavirus, SARS virus, SARS‐CoV‐2 | Positive‐sense single‐stranded RNA | Cytoplasm | Enveloped | Spherical with projections |
Herpesviridae | Varicella zoster virus (chickenpox) | Double‐stranded DNA | Nucleus | Enveloped | Icosahedral |
Orthomyxoviridae | Influenza virus | Negative‐sense single‐stranded RNA | Nucleus | Enveloped | Spherical or filamentous |
Paramyxoviridae | Measles, mumps, parainfluenza, respiratory syncytial viruses, human metapneumovirus | Negative‐sense single‐stranded RNA | Cytoplasm | Enveloped | Spherical or variable |
Picornaviridae | Rhinovirus | Positive‐sense single‐stranded RNA | Cytoplasm | No envelope | Icosahedral |
Togaviridae | Rubella virus | Positive‐sense single‐stranded RNA | Cytoplasm | Enveloped | Icosahedral |
The most popular explanations of the winter seasonality of respiratory viruses fall into three categories, designated here as followsa: E1, crowding of human hosts in winter encourages transmission; E2, ambient conditions allow respiratory viruses to survive outside the body longer in cold and dry conditions; E3, the immune defences of human hosts are weaker during the winter months. These explanations are important, but do not describe the main drivers of epidemic timing.
Crowding (E1) would predict that summer sporting events and festivals would be associated with increased respiratory illness, which is not the case. Tamerius et al. showed this lack of association for influenza. 2 Figure 3 shows that ‘Google flu search’ did not increase in any country in the Northern Hemisphere during the FIFA 2014 football World Cup,b despite spectators and fans packing into crowded bars, restaurants and homes to view World Cup matches. School vacations are not well‐correlated with respiratory illness. For example, children are on vacation in Singapore in December, which coincides with the yearly peak of influenza. 2 The crowding hypothesis E1 would also predict that colds and flu would be much more prevalent in large cities than in the countryside, which is not the case. 5
Survival (E2) focuses on the suggestion that cold and dry conditions increase the survival of the virus outside the body, thereby encouraging transmission. The corollary is that E2 would also predict that colds and flu would be rare in warm, wet or humid weather. However, in tropical locations that have rainy seasons, colds and flu are most prevalent during those seasons, when humidity is likely to be high. 2 , 6 It has been suggested that air conditioning in the Tropics may enhance viral survival by cooling and drying indoor air. 7 However, in some Tropical locations such as Fortaleza (Brazil), temperatures during the rainy season are slightly lower than in the dry months, so air‐conditioning use is unlikely to be higher, yet colds and flu are much more prevalent in the rainy season. 2 , 6 Also, World Health Organization reports show that influenza was common year‐round in the Tropics during the period 1964–1975, a time when most people in the Tropics did not have air conditioning. 8
The effect of humidity on virus survival can be examined experimentally. Table 2 summarises studies where viruses were introduced as aerosols into rotating drums with controlled humidity. The survival of some viruses, including influenza A, improved in dry conditions, but when influenza A viruses were supplemented with material from the apical surface of human airway epithelial cells they remained equally infectious when relative humidity was varied from 23% to 98%. 9 Moreover, other viruses, including rhinovirus‐14, rhinovirus‐16, and adenovirus, were more stable in humid conditions. 10 , 11 , 12 The illnesses caused by these viruses are nevertheless seasonal in temperate regions in the cold, dry air of winter, with virtually all other viral respiratory illnesses. None of this information supports the idea that it is the dry conditions of winter specifically that are ideal for the survival of respiratory viruses and thus explain the timing of cold and flu seasons.
TABLE 2.
First author | Year | Ref. | Respiratory virus | Presence of lipid envelope | Association between virus survival and relative humidity |
---|---|---|---|---|---|
Harper | 1961 | 103 | Influenza A | Enveloped | Anti‐correlated |
Songer | 1967 | 104 | Newcastle disease virus | Enveloped | Anti‐correlated |
Songer | 1967 | 104 | Infectious bovine rhinotracheitis | Enveloped | Correlated |
Akers | 1968 | 105 | Mengovirus 37A | Non‐enveloped | Correlated |
Hugh‐Jones | 1973 | 106 | Newcastle disease virus | Enveloped | Correlated |
Schaffer | 1976 | 107 | Influenza A | Enveloped | Least stable at 50% RH |
Elazhary | 1979 | 108 | Infectious bovine rhinotracheitis | Enveloped | Variable, usually anti‐correlated |
Elazhary | 1979 | 109 | Bovine adenovirus 3 | Non‐enveloped | Correlated |
Elazhary | 1979 | 12 | Bovine parainfluenza type 3 | Enveloped | Anti‐correlated |
Karim | 1985 | 10 | Rhinovirus‐14 | Non‐enveloped | Correlated |
Ijaz | 1985 | 110 | Human coronavirus 229E | Enveloped | Peaks at 50% RH (20°C) |
Schoenbaum | 1990 | 111 | Pseudorabies | Enveloped | Peaks at 55% RH |
Kormuth | 2018 | 9 | Pandemic influenza A (H1N1) | Enveloped | Viruses supplemented with material from airway cells were equally infectious at all humidities |
Schuit | 2020 | 112 | SARS‐CoV‐2 | Enveloped | No effect in darkness, variable in sunlight |
Niazi | 2021 | 11 | Rhinovirus‐16 | Non‐enveloped | Lowest survival around 50% (static RH). 97% of the virus was lost during the transition from 80% to 50% RH. |
Abbreviation: RH, Relative Humidity.
Studies also show that the onset of respiratory illness outbreaks in response to temperature change is too rapid to be caused by increased transmission via conditions favouring virus survival. A study by Lidwell et al. examined the effect of weather on colds that were recorded during 5000 person‐years in two cities in the UK during the 1950s 13 The strongest correlation was between colds and temperatures recorded only two to three days before the onset of colds, with a correlation coefficient of −0.162. 13 Van Loghem carried out a similar large‐scale study in the Netherlands during the winter of 1925/26, 14 and found a similar very rapid response of colds to temperature falls, too fast to be caused by increased transmission (Figure 4). Hajat et al. found an association between low temperatures and an increase in lower respiratory tract consultations in 16 urban locations in the UK. 15 The authors also tracked relative humidity but found only ‘a weak non‐linear relationship’ with health outcomes, indicating that increased virus survival with low humidity was likely not a cause. Fluctuations in ambient temperature are what appear to be crucial for most respiratory viruses, with rapid starts to outbreaks that cannot be accounted for by increased transmission.
A recent review of Covid‐19 data subscribes to the virus survival explanation, but mostly focuses on absolute temperature and humidity, not weather changes, and concludes that much of the data is confounded with public policies implemented in the reaction to the pandemic. 16 However, Covid‐19 outbreaks in many areas have followed regional weather patterns. The autumn 2020 wave of Covid‐19 in the USA began in the Midwestern states, 17 , 18 which experienced two severe, record‐breaking cold snaps in September and October 2020. 19 SARS‐CoV‐2 data will continue to stream in, but it (already) appears to be affected by weather changes too rapid to be accounted for by increased transmission.
The immune defences (E3) explanation assumes that the immune system does not function as well in the colder, darker conditions of winter in temperate regions. However, Paynter et al. found that vaccines were slightly more effective in winter than in summer. 20 An early study on an isolated tropical island found that colds increased in September when the temperature dropped by only 1°C–2°C, from around 24°C at night to around 22°C. 21 It seems implausible that such a small temperature drop, starting at a relatively high temperature, could meaningfully depress human immunity. Experimental studies by Andrewes, and Dowling et al., suggested that immune defences are not made meaningfully weaker by experimental chilling of individuals (although these studies used ‘pedigree’ viral strains that may behave differently from wild‐type strains, discussed below). 22 , 23
Others propose that the winter seasonality of Covid‐19 and other viral illnesses is driven by vitamin D deficiency due to reduced sunlight during the winter months. However, vitamin D levels typically peak in September in temperate locations (Figure 5), 24 which is when the autumn surge of respiratory illness arrives (Figure 2). Also, vitamin D levels change slowly, typically over a few months (Figure 5), whereas respiratory illness often follows temperature drops within two weeks (Figure 4). Lastly, colds and flu do not follow overcast weather, and do not decrease after sunny weather. 13 Lack of vitamin D or other deficiencies brought on by insufficient sunshine may contribute to the prevalence of colds and flu in late winter and early spring,c but they are unlikely to be the main drivers of winter seasonality. 25 , 26
2.2. Common viruses worldwide
Table 3 lists the viruses that most frequently caused hospitalization of children in three studies based at hospitals at different latitudes. 3 , 4 , 27 There are striking similarities. Moreover, viral respiratory illnesses are rare in mid‐summer in temperate regions, but they usually occur throughout the year at moderate levels in the Tropics (sometimes with a surge in the rainy season 6 ). For example, Figure 6 shows that influenza is almost absent during the summer in Northern USA and Sydney (Australia), but it is present year‐round in Singapore and during the rainy season in Fortaleza (Brazil). The same trends can be seen in the prevalence of influenza reported by the World Health Organization for the period 1964–1975. 8
TABLE 3.
City | Ref. | Climate | Most common respiratory viruses causing hospitalization of children |
---|---|---|---|
Mainz, Germany | 3 | Oceanic | Rhinovirus, RSV, influenza A, adenovirus |
Buenos Aires, Argentina | 4 | Humid subtropical | RSV, influenza A, adenovirus, parainfluenza |
Singapore | 27 | Tropical | RSV, parainfluenza, influenza A, adenovirus |
Abbreviation: RSV, respiratory syncytial virus.
2.3. Rapid arrival and termination
As characterized by Hope‐Simpson, an ‘explosive’ arrival and rapid termination is observed for many epidemics of influenza and other endemic respiratory viruses (Figure 7). Influenza frequently arrives simultaneously throughout large geographical areas, in isolated remote rural settings and nearby towns and cities, and even widely separated locations at similar latitudes. 5 , 8 Hope‐Simpson showed extraordinary synchronisation in influenza epidemics arriving in Cirencester (UK) and Prague between 1969 and 1974, including an antigenic shift from A/HK/68 to A/ENG/42/72 in 1972 and a transition to influenza B in 1973. 8 , 28 Figure 8 shows that during the Spanish Influenza epidemic of 1918/19 most European countries experienced a single peak of mortality during a two‐month window (October and November 1918), with winter mortality returning to normal levels in all but four countries in 1920. 29 For Covid‐19, cases have rapidly decreased at unexpected times during the pandemic. 30 , 31 For example, the World Health Organization reported that at the end of January 2021 Covid‐19 cases declined in five of six world regions (the exception being tropical South‐East Asia) in spite of a lack of widespread immunity and limited vaccination. 32
3. THE FOUR PREMISES OF TEMPERATURE DEPENDENT VIRAL TROPISM (TDVT)
The hypothesis explains the four features of seasonal respiratory outbreaks listed above. It is built on four simple premises:
Very pathogenic viruses reduce the mobility of their hosts. In well‐established endemic viruses, mild or moderately virulent strains are selected because they are more likely to be transmitted to new hosts than more pathogenic ones.
In the case of respiratory viruses, most moderate their pathogenicity by having one or more ts steps in their lifecycle (Figure 9(a)), such that they replicate best below normal body temperature. Less ts strains are more likely to invade the lungs and internal organs and are therefore more virulent. (Note that most biological processes slow down at lower temperatures, so this is unusual).
This thermal sensitivity confines most respiratory viruses to the nose and throat, where they can cause coughing, sneezing and runny noses, all of which can help to transmit them to other hosts.
If ambient temperature remains stable, or rises, ts respiratory viruses often remain dormant in the respiratory tracts of their hosts. If ambient temperature drops or hosts are chilled they are likely to become active and may cause respiratory illness.
Based on these premises, this review concludes that the seasonality of viral outbreaks is mainly a consequence of viral thermal sensitivity. Natural selection causes the level of thermal sensitivity to adapt to local conditions. Thermal sensitivity therefore varies with the seasons and in different climates as discussed below.
The Nobel laureate André Lwoff suggested part of the hypothesis in 1959, when he noted that the degree of virulence of viruses is often related to their level of thermal sensitivity. 33 In 1979, Richman and Murphy developed this further, discussing many examples of thermal sensitivity in natural and lab‐made viral strains, and noting that the near‐universal attenuation of ts strains made them good candidates for vaccines. 34 The full hypothesis was proposed by Shaw Stewart and discussed at length in 2016, focusing on seasonality and the natural selection of strains with varying degrees of thermal sensitivity and pathogenicity. 28 The same hypothesis was put forward by Eccles in 2020, this time concentrating on the advantages of thermal sensitivity to the virus. 35 The current shorter review summarises the evidence for TDVT, including recent studies, and discusses its implications for avoiding and treating respiratory illness including Covid‐19.
3.1. Premise #1: mild or moderately pathogenic endemic viral strains are more likely to be transmitted
Viral infections that humans occasionally pick up from other animals, normally vertebrates, may cause mild flu‐like symptoms, but they may also be highly pathogenic. For example, at least five unrelated groups of RNA viruses have been identified as causes of human hemorrhagic fevers. These illnesses cause internal or external bleeding and are often fatal. Examples include Whitewater Arroyo virus fever, Rift Valley fever and Lujo virus. The hemorrhagic fevers caused by Marburg virus, Lassa fever virus and Ebola virus have been seen to spread between human hosts. 36 Other viruses that ‘spilled over’ to humans from other species and caused epidemics with high mortality include Spanish influenza virus, HIV, SARS‐CoV, MERS‐CoV and SARS‐CoV‐2. Clearly these viruses are not yet well‐adapted to their hosts, yet they are much more pathogenic than most well‐established endemic viruses such as cold viruses, supporting the proposal that selective pressures result in a loss of virulence as viruses adapt to their hosts.
The moderation of viral pathogenicity is predicted by the ‘transmission‐virulence trade‐off’ hypothesis. 37 This states that the benefits of increased replication (including increased shedding) must be balanced against the reduction of time during which shedding takes place, and the reduced mobility of hosts. The trade‐off hypothesis was introduced to explain patterns in myxomatosis data. 37 Myxomatosis has been studied intensely because it provides a classic reference for the rapid evolution of virulence. It is a highly pathogenic viral disease, normally spread by mosquitos, that jumped from New World rabbits to European rabbits. During the first year after its introduction to Australia, it is estimated to have killed 99.5% of the rabbits that it infected. 38 Within ‘a few years’ genetic resistance to the disease in rabbits increased in some areas, but independent testing with laboratory rabbits showed that milder viral strains emerged more rapidly. For example, a virulent (grade I) strain was introduced to rabbits at Lake Urana in 1952, causing an outbreak with a case‐mortality rate of over 99.5%. 38 Eleven months after the first outbreak ended, a new outbreak occurred that was caused entirely by attenuated strains of grade III severity. The over‐all trend towards moderate virulence (grade III) can be explained by the selective advantage for mosquito transmission of strains that cause extensive and long‐persisting infectious skin lesions in rabbits. 38 Interestingly, when mild strains (grade IV) were introduced they often evolved increased virulence, and grade III strains were later recovered. Similar selection can act on respiratory viruses, such that strains with intermediate pathogenicity emerge.
There is other evidence for the moderation of virulence in viral infections. If natural selection tends to reduce the severity of the most pathogenic illnesses such that the period of transmission can increase, there should be differences between illnesses that are transmitted by insects (or other vectors) compared to those transmitted by direct contact. This is because transmission via vectors can take place whether or not the host is immobilised, whereas direct contact between individuals will be reduced by immobilisation. Ewald, who introduced an early version of the trade‐off hypothesis in 1983, showed that pathogens that are transmitted without vectors are significantly more likely to cause illnesses that have mortality below 1% than those transmitted by vectors (p < 0.0005). 39 More virulent pathogens may also be strongly selected in settings such as hospitals and care homes, 40 where transmission can take place even when individuals are very sick if adequate protective measures are not taken.
3.2. Premise #2: most respiratory viruses are ts. Less ts strains are more virulent, and vice versa
Despite practical difficulties in carrying out experiments, viral thermal sensitivity (i.e., viruses replicating faster at temperatures below body temperature) has been observed in the wet lab on many occasions. Moreover, if selective pressure is applied in the laboratory and more mutations occur, thermal sensitivity can also be lost or regained in both cells and animal hosts.
It is often easier to propagate respiratory viruses that are freshly collected from patients by incubation at temperatures below 37°C. Table 4 summarises numerous studies that observed optimal temperatures for virus isolation or propagation. In several of these studies, viruses were propagated at one temperature, but found to be more prolific growers at lower temperatures, demonstrating the ts nature of these viruses. 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49
TABLE 4.
First author | Ref. | Virus | Host | Temperature conducive to growth | Temperature sub‐optimal for growth | Observation |
---|---|---|---|---|---|---|
Price | 41 | Rhinovirus | Monkey kidney cells | 35°C | First isolation of rhinovirus | |
Tyrrell | 42 | Three rhinoviruses | Human kidney cells | 33°C | Isolation of three rhinoviruses | |
Bradburne | 43 | Coronavirus | Human lung fibroblasts | 33°C | First isolation of coronavirus | |
Stern | 44 | H2N2 ‘Asian’ influenza A | Eggs and monkey kidney cells | 33°C | 37°C | Viral replication only at low temperature |
Stern | 44 | PR8, FM1 and two more recent H1N1 influenza A strains | Monkey kidney cells | 33°C | 37°C | One order of magnitude higher titres at the low temperature |
Kung | 45 | H1N1 "Russian” influenza A | Embryonated chicken eggs | 33°C | 38°C –39°C | 9 of 10 strains isolated in China were ts |
Oxford | 46 | H1N1 "Russian” influenza A | Canine kidney cells | 34°C | 38.5°C | 17 of 26 strains isolated in Hong Kong, USA, UK, China and USSR were ts |
Jardon | 47 | Recombinant adenovirus | Human embryonic kidney cells | 34°C | 37°C | Three‐fold increase in virus yield at the low temperature |
Sato | 48 | Parainfluenza viruses 1 and 3 | Human melanoma cells | 34°C | Recommended temperature for virus isolation | |
Sato | 49 | Human metapneumovirus | Human melanoma cells | 33°C | Recommended temperature for virus isolation |
Viral strains can adapt to higher temperatures and lose thermal sensitivity if the right selective pressure is applied in the laboratory. Most laboratory strains of respiratory viruses are propagated in cell cultures at around 37°C, which may result in the rapid loss of ts characters, especially since viruses often mutate very rapidly when introduced to new hosts. For example, a study looking specifically at the effect of temperature on the replication of H1N1, H1N2 and H3N2 influenza A viruses found that only 3 of 7 strains examined consistently replicated faster at 37°C than 40°C. 50 These strains had, however, been propagated at unknown temperatures in the laboratory for up to 23 years, and all strains were ‘amplified’ at 36°C–37°C in eggs for a few days before the study. This procedure might have selected sub‐strains lacking thermal sensitivity. This has been seen in earlier studies ‐ the ts character of strains was lost in conditions that allowed rapid replication. Chu et al. passaged a naturally occurring ts subclone of the influenza A H3N2 strain Ningxia/11/72 three times through chicken embryos at a low temperature (33°C), and were surprised to find a non‐ts strain. 51 Similarly, Oxford et al. found that when a naturally occurring ts virus, A/Eng/116/78 (H1N1), was passaged five times through chicken eggs at 33°C it progressively lost its ts character. 46 Both groups concluded that the ts phenotype may confer a selective disadvantage in eggs because eggs allow rapid replication of influenza virus.
The converse trend has been seen: conditions that favour the replication of milder strains have produced ts strains. Three reports described the establishment of persistent infections of cell cultures by spontaneously generated ts strains of influenza A. 52 , 53 , 54 In a review from 1975, 55 Preble and Youngner noted that ts strains often appear spontaneously in persistent infections of cell cultures with a variety of unrelated insect‐transmitted and respiratory viruses, including Newcastle disease virus, vesicular stomatitis virus, and Sindbis virus. The authors pointed out that a balance between viral and cell replication is required to establish persistent infections and that since ts strains tend to be less virulent they may allow such infections to become established. 55 Similar mechanisms may allow the establishment of persistent infections in animals. For example, foot‐and‐mouth viruses recovered from carrier animals are frequently ts, whereas the replication of isolates from animals withacted by temperature. 56
Table 5 lists a number of laboratory studies that showed that particular steps in the life cycles of viruses were ts. 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 For example, Russell found that the entry of a reassortant influenza A virus into cells was ts (Figure 10). Virologists tend to focus on mutations that change the sequences of viral proteins. However, RNA secondary structure is known to affect protein expression and has been shown to control the expression of the proteins NS1 and NEP during influenza A infection. 68 RNA secondary structure is inherently ts, and conserved RNA structures (such as, in SARS‐CoV‐2, the s2m structure, the 3′ UTR pseudoknot, and the coronavirus packaging signal) may comprise ‘RNA thermometers’ contributing to the thermal sensitivity of such viruses. 69 Two studies found that temperature affects the balance between transcription and viral replication. 64 , 66 ‘Silent’ mutations that affect RNA secondary structure may have profound effects on the pathogenicity of respiratory viruses 67 including SARS‐CoV‐2.
TABLE 5.
First author | Ref. | Virus | Host/assay system | Temperature conducive to activity | Temperature sub‐optimal for activity | Observation |
---|---|---|---|---|---|---|
Fei | 58 | Influenza H3N1, A/Memphis/71 | A glycan‐microarray‐based assay platform | 15°C | 25°C | The dissociation constant was an order of magnitude higher at the high temperature, implying weaker binding of virus to glycans. |
Russell | 57 | Triple reassortant influenza A | Bovine kidney cells | 30°C | 38°C | 100% of virus entered cells at low temperature, 50% at high (Figure 10). |
Takashita | 59 | Influenza C/Ann Arbor/1/50 | Monkey kidney cells | 33°C | 37°C | Twice as much haemagglutinin‐esterase‐fusion (HEF) protein on the cell surface at low temperature compared to high. Cell fusion at low temperature only. HEF trimer unstable at 37°C. |
Plotch | 60 | Influenza A/WSN/1933 | Bovine kidney cells | 30°C–32°C | Greatest activity of the viral RNA polymerase. | |
Muraki | 61 | Influenza C/Ann Arbor/1/50 | “Reverse genetic” system | 33°C | Greatest activity of the viral RNA polymerase. “Viral proteins function most efficiently” at this temperature. | |
Nagele | 62 | Influenza 3HB t/66 | In vitro system | 30°C–33°C | 40°C | Greatest activity of the viral RNA polymerase at low temperature. At high temperature activity ceased. |
Ulmanen | 63 | Influenza A/WSN/1933 | In vitro system | 33°C | 39.5°C | The fraction of capped RNA primers bound to viral cores at high temperature was unexpectedly reduced relative to the fraction bound at low temperature. |
Scholtissek | 100 | Rostock strain of fowl plague virus | Cytoplasmic extract of infected chick fibroblasts | 36°C | 41°C | Greatest activity of the viral RNA polymerase was at low temperature. At high temperature the viral RNA polymerase was unstable in vitro and in vivo. The synthesis of haemagglutinin and neuraminidase was unimpaired at high temperature. |
Kashiwagi | 64 | Two H5N1, two H1N1 and one H3N2 influenza A strain | Human embryonic kidney cells expressing various influenza ribonucleoproteins | 37°C | 42°C | For all strains, viral mRNA increased at high temperature. Genomic RNA (vRNA) production was higher at low temperature. |
Ngai | 65 | Various influenza A strains | Viral RNA polymerase subunits were expressed in human kidney cells | 33°C | 37°C | 2009 pandemic H1N1 RNA polymerase showed significantly higher activity at low temperature. H3N2 showed about 80% higher activity at low temperature, while the highly pathogenic H5N1 strain showed higher activity at high temperature. |
Dalton | 66 | PR8 influenza A/PR/8/34 | Human embryonic kidney cells | 37°C | 42°C | High temperature caused a large decrease in vRNA production and a moderate decrease in cRNA production, but (depending on genome segment) either increased or did not affect mRNA production. |
Chursov | 67 | Wild‐type and cold‐adapted temperature‐sensitive influenza A | Analysis by “a novel in silico method” | 32°C | 39°C | Areas in the NS2, PA, PB2 and NP mRNAs were predicted to have dissimilar secondary structure (which also varied between wild‐type and cold‐adapted strains) at high and low temperatures. |
Abbreviation: HEF, haemagglutinin‐esterase‐fusion; NP, nucleoprotein; vRNA, viral mRNA.
3.3. Premise #3: thermal sensitivity confines respiratory viruses to the nose and throat; coughing, sneezing and runny noses encourage transmission
The human respiratory tract is normally colder than most other areas of the body. McFadden et al. showed that there is a temperature gradient that runs from the nostrils (which are close to the temperature of the air being breathed) to the lungs (which are at body temperature). 70 For example, during quiet breathing of room air the lining of the upper trachea was at 32.0°C, but the subsegmental bronchi were at 35.5°C. The temperature of the respiratory tract fluctuated on each breath, and both breathing colder air and exercise rapidly reduced the temperature.
TDVT suggests that since most respiratory viruses are ts, they will not normally replicate in the lungs and internal organs. In 1979 Richman and Murphy pointed out that ts influenza, RSV, parainfluenza, and foot‐and‐mouth consistently replicated more rapidly in the nasal cavities of a variety of animals than in their lungs. 34 Many ‘live’ vaccines use thermal sensitivity to attenuate the strains used, including avoiding lower respiratory tract infections. For example, the FluMist vaccine developed by MedImmune uses a ts strain that replicates at 25°C but not body temperature, 37°C–39°C. 71
If respiratory viruses enter the bloodstream, TDVT predicts that they may settle and can replicate in other cold tissues such as the skin and the extremities. Virulent human influenza strains occasionally cause rashes. For example, three children who were infected with pandemic H1N1 influenza (‘swine flu’) in 2009 presented with petechial rashes. 72 Chilblains are normally considered to be an inflammatory skin condition related to ‘an abnormal vascular response to the cold’. They typically present as tender red or bluish lesions located on the dorsal aspect of the fingers, toes, ears and nose. 73 TDVT suggests that at least some chilblains could be caused by the replication of virus in the extremities. Covid‐19 is associated with chilblain‐like symptoms referred to as ‘Covid toes’ that mainly occur in older children and adolescents, although it has not yet been shown that they are caused by the presence of the virus in the feet. Figure 11 shows plaque‐like blemishes of different sizes on the feet of a 16‐year‐old boy that may possibly represent the sites where individual virions established replication. Covid‐19 also causes a variety of other skin rashes and blisters. 74 (An alternative explanation is that lung thrombosis might give rise to microemboli in the brain, solid organs and skin 75 ).
TDVT also can shed light on the febrile response to infection. The response is well‐preserved across the animal kingdom, and cues delivered by the thermal element of fever are known to stimulate both innate and adaptive immune responses. 76 It is, however, not clear why raised temperature is used as a protective signal in addition to chemical signals (cytokines and hormones). If, as suggested by TDVT, most respiratory viruses are inhibited by higher temperatures, fever may slow their replication throughout the body. It is interesting that reducing fever by the administration of antipyretics in a randomised prospective study in the ICU was associated with negative outcomes and increased mortality (although the trend was not statistically significant, p = 0.06). 77
3.4. Premise #4: ts respiratory viruses often remain dormant in the respiratory tracts of their hosts. If ambient temperature drops or hosts are chilled the viruses may become active and cause sickness
Table 6 summarises several studies showing the presence in people of a variety of out‐of‐season or dormant viruses, even in asymptomatic individuals. 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 A large‐scale community study in New York City found that, on average, only 30% of detectable infections caused by 18 common respiratory viruses were symptomatic. 85 Influenza and metapneumovirus were most pathogenic, with roughly 50% and 70% of cases being symptomatic respectively. Moreover, roughly as many individuals were carrying respiratory viruses in summer as in winter. 84 Shaman and Galanti found that 50% of infections caused by the endemic coronaviruses within families were asymptomatic. 83 Table 6 includes studies of respiratory viruses in Antarctica that showed dormancy. 86 , 87 , 88 In one example, parainfluenza shedding occurred throughout the winter isolation period, with two episodes of respiratory illness. 88 Other studies in the community identified asymptomatic individuals who had not seroconverted, but who were shedding influenza A 78 , 80 , 81 or influenza B. 79 Thai et al. commented that this ‘may indicate that viral RNA remained in the respiratory tract without being internalised and eliciting an immune response’. 78
TABLE 6.
First author | Year | Ref. | Viral species studied | Observation |
---|---|---|---|---|
Galanti | 2019 | 84 | Influenza, RSV, parainfluenza, metapneumovirus, rhinovirus, adenovirus, coronavirus | Asymptomatic infection rates exceeded 70% for most viruses, excepting influenza (45%) and metapneumovirus (30%), which produced significantly more severe outcomes. |
Galanti | 2019 | 85 | Influenza, RSV, parainfluenza, metapneumovirus, rhinovirus, adenovirus, coronavirus | Roughly as many individuals were carrying respiratory viruses in summer as in winter. |
Shaman | 2020 | 83 | The endemic coronaviruses HKU1, 229E, NL63, and OC43 | 50% of infections were completely asymptomatic within 9 family clusters. |
Granados | 2015 | 82 | Human rhinovirus | Asymptomatic rhinovirus activity preceded peak symptomatic activity in September and October and was associated with lower viral load. |
Tandale | 2010 | 81 | 2009 pandemic influenza A (H1N1) | Almost 90% pandemic H1N1 infections were asymptomatic or mild. 18% of PCR‐confirmed cases had not seroconverted. |
Papenburg | 2010 | 80 | 2009 pandemic influenza A (H1N1) | Two asymptomatic cases were detected by RT‐PCR that had not seroconverted. |
Thai | 2014 | 78 | 2009 pandemic influenza A (H1N1) | Four asymptomatically infected contacts had blood collected for serology, of which three had seroconverted. |
Foy | 1987 | 79 | Influenza B | Of 37 persons shedding virus, 12 were asymptomatic. Of these, 10 did not respond with antibody by any of the five test methods employed. |
Cameron | 1968 | 87 | Unidentified respiratory virus | Antarctic study. After 12 months of isolation, a respiratory virus was picked up by one individual from a visiting field party (who had already spent more than one month in Antarctica). 17 days after transmission muscle aches and sore throats were experienced by four men after exposure to cold and damp conditions. |
Allen | 1973 | 86 | Unidentified respiratory virus | Antarctic study. After 17 weeks of complete isolation several men developed colds 7 days after the air temperature fell in 3 days from 0°C to–24°C. |
Muchmore | 1981 | 88 | Parainfluenza | Antarctic study. Parainfluenza virus was shed by healthy young adults throughout the 8½‐month winter isolation period. Two episodes of respiratory illness caused by parainfluenza occurred after 10 and 29 weeks. |
Abbreviations: PCR, polymerase chain reaction; RSV, respiratory syncytial virus.
Since dormant respiratory viruses are often present in the respiratory tracts of otherwise healthy individuals, and since TDVT suggests that such viruses will be activated by local temperature drops, the hypothesis predicts that cold‐weather snaps will cause surges in respiratory disease (Figure 4). In another Antarctic example, several men developed colds after the air temperature fell from 0°C to 24°C. 87 In 1919, Mudd and Grant, two American doctors, reported that chilling of the body surface (e.g. by placing a wet towel on the back) caused a rapid reduction in the blood flow to the lining of the respiratory tract, together with a rapid fall in its temperature. 89 This physiological response may cause respiratory sickness after specific chilling events such as wearing wet clothing after rainfall or entering a building kept very cold by air conditioning. 7
A study from 1997 by the Eurowinter Group examined the effect on mortality of exposure to cold. The study found correlations between cold‐exposure factors and death from respiratory illness in seven regions of Europe. 90 Factors that increased personal chilling such as wearing a skirt (p = 0.005), and shivering outside (p = 0.001) were significantly correlated with increased risk of death from respiratory illness (Figure 12). Factors that reduced personal chilling such as wearing a hat outside (p = 0.004) and outdoor exercise sufficient to cause sweating (p = 0.02) were significantly correlated with reduced risk of death from respiratory illness. The finding that protection from viral infection is correlated with outdoor exercise with sweating is particularly interesting. This requires explanation by a combination of TDVT and E3. TDVT says that breathing cold air can ‘wake up’ dormant virions, while E3 says that the lack of chilling, and the good blood flow to the nose and throat (implicit in the stipulation of sweating), may ensure that batches of activated virions ‐ presumably now visible to the immune system ‐ can be destroyed by our defences. Note that the Eurowinter Group found that frequency of going outside was not significantly correlated with reduced mortality, suggesting that this apparent protective effect is not solely driven by the regular activation, by cold, of virions in small batches. 90
Several studies from the 1950s and 1960s, however, have been interpreted as showing that body chilling does not increase the chance that individuals will suffer from respiratory illness (Table 7). Two influential studies by Dowling et al. and Andrewes were performed with volunteers who were inoculated nasally with suspensions of recycled cold viruses (of unknown species) taken from previous volunteers. 22 , 23 When individuals were subsequently chilled, the studies found that they were no more likely to get colds than unchilled individuals, and the authors concluded that chilling does not bring on colds. Since these experiments were designed to be carried out within a limited time‐frame, often one week, and infections had to appear quickly if they were to be recorded, it is possible that unusual fast‐acting viral strains that had lost their natural thermal sensitivity were selected over time. 28 Another study using a type‐15 rhinovirus did find that 16% more of the chilled group developed colds than the unchilled one, but, because the results did not reach statistical significance, the authors reported a ‘failure to demonstrate effect’. 91 Moreover, the strain used was isolated eight years before the study and grown in WI‐26 cells, a cell‐line that is routinely propagated at 37°C. 92 It is therefore likely that this strain, like many other laboratory strains, had lost much of its natural thermal sensitivity by the time the study was carried out. Therefore, it is possible that chilling increases the risk of getting a cold caused by a ‘wild’ virus, but not a cold caused by a virus such as was used in these studies.
TABLE 7.
First author | Year | Ref. | Respiratory virus | Chilled subjects‐ results | Warm subjects‐ results | Comments |
---|---|---|---|---|---|---|
Andrewes | 1950 | 22 | “Pedigree” (i.e. recycled) virus | Roughly equal numbers of chilled and warm subjects developed colds | The study used 12 chilled and 12 warm subjects | |
Dowling | 1958 | 23 | “Secretions obtained from patients with typical common colds” | 88/253 (35%) of those inoculated developed colds | 63/175 (36%) of those inoculated developed colds. | Some individuals were not inoculated: 7% of chilled subjects and 16% of warm subjects developed colds |
Jackson | 1960 | 113 | Specimens from “donors with naturally acquired typical common colds”, or “a virus grown in tissue culture” | Approx. 100/378 (26%) of those inoculated developed colds | Approx. 606/1650 (37%) of those inoculated developed colds | Some individuals were not inoculated: ∼10% of chilled subjects and ∼12% of warm subjects developed colds |
Douglas | 1968 | 91 | Cultured rhinovirus 15 that was isolated approximately 8 years before the study | 4/9 subjects developed colds | 2/7 subjects developed colds | Because the numbers were small they were not statistically significant; therefore the authors reported a “failure to demonstrate an effect” |
Johnson | 2005 | 101 | ‘Wild’ viruses that the volunteers happened to be carrying | 13/90 subjects developed colds | 5/90 subjects developed colds | A significantly greater number of chilled subjects developed colds (p = 0.047) |
The pattern of dormancy followed by low‐temperature activation may explain the explosive arrival and abrupt termination of influenza epidemics recorded by Hope‐Simpson and others (Figure 7). TDVT suggests that a virus such as influenza can enter a community either without symptoms or with only minor symptoms. If the temperature drops, asymptomatic infections are converted to symptomatic by the activation of dormant viruses. If the temperature then remains stable, no further severe infections develop and the epidemic may end abruptly.
After an initial peak in SARS‐CoV‐2 test positivity in the spring of 2020, rates of illness dramatically decreased during the summer months in most countries situated in temperate locations of the Northern Hemisphere. 93 SARS‐CoV‐2 is estimated to cause completely asymptomatic infections in 17% of cases. 94 Case numbers remained low over the summer in many countries, perhaps because asymptomatic individuals were found to be 42% less likely to transmit the virus than symptomatic individuals. 94 Meanwhile, some areas in countries south of the Equator such as Brazil, Chile and Peru experienced major Covid‐19 epidemics during their cold and/or rainy seasonsd. Many countries are large enough to have significant regional variations in climate leading to staggered outbreaks. In the autumn, Covid‐19 surged across those countries according to climate, for example regions of the United States with the first cold weather systems saw the first outbreaks. 17 , 18 , 19 (The new cases may have comprised both dormant infections that had been activated by temperature, and new infections transmitted from these newly activated cases.) These observations suggest that despite being a recent ‘spill‐over’ to the human species, SARS‐CoV‐2 has retained or gained significant thermal sensitivity. The Covid‐19 pandemic is an emerging event, however, and additional data will be required to evaluate the effect of thermal sensitivity, as discussed below.
4. CONCLUSIONS
4.1. Seasonality of respiratory viruses is a result of thermal sensitivity; natural selection based on thermal sensitivity allows respiratory viruses to adapt to local climate conditions
As stated previously, the epidemiology of respiratory viruses still needs rigorous scientific explanations for these observations: (1) in temperate locations colds and flu are seasonal, with a sudden epidemic of colds and flu in the autumn and a rapid response to cold snaps throughout the cold season; (2) roughly the same set of viruses cause respiratory illness all over the world (Table 1), including tropical and temperate locations; and (3) viral outbreaks often begin and end suddenly. Previous explanations assign cause to crowding, enhanced virus survival in the winter, and/or weakened immune systems. However, each of these explanations has flaws when compared to the data on respiratory illnesses.
The four premises of TDVT presented here explain these characteristics of respiratory illness by suggesting that (1) mildly pathogenic endemic viruses are more likely to be transmitted; (2) most respiratory viruses use thermal sensitivity to moderate their pathogenicity; (3) thermal sensitivity helps respiratory viruses stay in the nasal cavity and throat, where they can be transmitted; and (4) viruses are often present but dormant in the nose and throat and can cause sickness if ambient temperature drops or hosts are chilled.
The autumn surge of respiratory illness in temperate locations (Figure 2) is explained by TDVT by assuming that viruses with a particular level of thermal sensitivity are selected according to the weather/climate, and that this process takes place within a few months. During the hotter weather of summer, the few wild‐type viral strains with low thermal sensitivity are likely to be selected because only less‐ts strains are able to replicate and be transmitted at higher temperatures. Other viral strains that are more ts may be dormant at this time. (The strains that we refer to as ‘less‐ts’ nevertheless retain substantial thermal sensitivity. TDVT suggests that if they were to lose all thermal sensitivity they would become highly pathogenic, comparable to the viruses that cause Ebola and other hemorrhagic fevers.) When ambient temperature falls in autumn, the temperature in the nose and throat also falls and the respiratory viruses that are already present quickly become more active, causing an increase in illness and transmission. In winter, the situation changes: the most virulent (less ts) strains now immobilise their hosts, so the more ts (less virulent) strains are most likely to be transmitted. When ambient temperature rises in the spring, these more ts viruses become less active and the number of colds is reduced. The net result is more colds and flu in winter, fewer in summer, with a surge in autumn. Figure 13 shows these trends schematically.
According to TDVT, respiratory viruses adapt to their local ambient temperature, so we can expect them to spread throughout the world over time and establish reasonably stable equilibria in all locations (albeit disturbed by seasonal temperature fluctuations in temperate locations). Figure 14 shows that influenza strains move freely around the world, but that strains are more likely to move from hotter to colder locations than in the opposite direction. This is predicted by TDVT because tropical strains need to be less ts to replicate in nose and throat at higher temperatures, and they are therefore intrinsically more virulent and expected to cause more serious illness if they are transported to temperate locations. Note that the same virus might colonize locations nearer the nose in the Tropics, and nearer the lungs in cold locations.
Studies that attempt to explain the influence of weather, seasonality, and environmental influences on Covid‐19 have yielded ‘contradictory’ and confusing results. 95 For example, Pan et al. looked at Covid‐19 cases in 202 locations in 8 countries, with matching meteorological data, and found that temperature did not exhibit significant effect on the transmissibility of Covid‐19. 96 However, Guo et al. looked at meteorological factors and Covid‐19 incidence in 190 countries and concluded that a higher temperature was associated with a lower incidence of Covid‐19. 97 Ward et al. determined that humidity has a significant effect on SARS‐CoV‐2 spread in Australia, 98 but Jamshidi et al. did not find that weather was a significant factor. 99 Note that many meteorological studies examined absolutes of humidity and temperature, not fluctuations. At the start of the pandemic, seasonality may have also been less important because SARS‐CoV‐2 could spread in any climate and season due to lack of immunity. However, as the virus approaches equilibrium, eventually becoming endemic, its thermal sensitivity may increase.
The autumn surge of colds (Figure 2) suggests that natural selection can adjust the thermal sensitivity of respiratory viruses within a few months. Since too high pathogenicity may reduce viral transmission (as patients become bed‐ridden), natural selection may adjust thermal sensitivity to a level that is appropriate to the virus's location, season and climate. These explanations fit the experimental data and observations of viral outbreaks with more rigour than previously offered arguments in favor of crowding, viral survival or immune defences.
5. PRACTICAL RECOMMENDATIONS ACCORDING TO TDVT FOR AVOIDING AND TREATING RESPIRATORY ILLNESSES
5.1. For avoiding respiratory illness (see Figure 12)
Dress warmly to avoid chilling. 90 Chilling reduces the temperature of the lining of the respiratory tract, allowing dormant respiratory virions to become active and replicate. 89
Avoid standing still outdoors in cold temperatures. 90
Take regular outdoor exercise sufficient to cause sweating. 90 It seems likely that breathing cold air activates dormant virions ‐ making them visible to the immune system ‐ while dressing warmly improves immune defences in the respiratory tract. 28 Note that the combination of cold air and warm clothing seems to be protective.
5.2. For treating existing respiratory illness
Keep the temperature of the patient constant and warm.
Do not take exercise when symptoms begin. Rapid breathing cools the respiratory tract 70 and it would be unhelpful to increase the load by activating more virions.
Keep the air in the sick‐room warm to increase the blood flow to the respiratory tract. 89
-
Food and beverages should be at room temperature or warm, not hot.
Chilled items may cool the throat and encourage viral replication.
Hot drinks are also not recommended. Although viruses often replicate faster at lower temperatures, other viral processes may be activated by warmer temperatures. For example, several studies showed that the production of influenza viral proteins increased at temperatures above the normal temperature of the respiratory tract. 64 , 66 , 100
5.3. Future work for the validation of TDVT
The hypothesis is testable at many levels, and suggestions for experiments have already been made. 28 Important suggestions include:
Systematically survey the best temperatures for propagating wild‐type respiratory viruses in tissue cultures.
Infect animals with labelled respiratory viruses and determine the positions of replicating viruses in the respiratory tracts of animals that have experienced different temperature regimes (i.e., temperature‐shift time‐course experiments, see Figure 9(b)).
Follow viral entry (Figure 10), transcription, splicing, translation, genomic replication, assembly and release of daughter virions from cells in temperature‐shift experiments (Figure 9(b)).
Investigate the effect of mutations on thermal sensitivity, including effects on RNA secondary structure, possibly using DNA‐based ‘recombinant’ systems (because DNA sequences are much more stable than the RNA sequences of replicating viruses). Low temperature may directly affect mammalian cell‐lines independently of viral infection, hindering interpretation of experiments. However, the effect of different viral sequences can be compared by running them in parallel, allowing clear interpretation of results. Two separate studies of H1N1, H5N1 and H3N2 influenza used this approach (Table 5). 64 , 65
Run randomised controlled studies to test the recommendations given above for avoiding and treating respiratory illnesses, using for example “wild” respiratory viruses that individuals happen to be carrying during the experiment, following the approach of Johnson and Eccles. 101
AUTHOR CONTRIBUTION
Patrick Shaw Stewart and Julia Bach contributed equally to this article. The article is based on a hypothesis that Patrick Shaw Stewart published in 2016.
Shaw Stewart PD, Bach JL. Temperature dependent viral tropism: understanding viral seasonality and pathogenicity as applied to the avoidance and treatment of endemic viral respiratory illnesses. Rev Med Virol. 2022;32(1):e2241. 10.1002/rmv.2241
ENDNOTES
These explanations were designated M1, M2 and M3 in the 2016 review by Shaw Stewart. They have been changed to E1, E2 and E3 because the previous designations confused some readers. M4 becomes TDVT in this review.
Google flu search. Retrieved August 2015. Google Flu Trends was a web service operated by Google that attempted to make predictions about influenza activity. After Google ceased publishing Flu Trends in August 2015, the graphical data for related searches was still available as ‘Google flu search’.
Epidemiological studies show that vitamin D deficiency is associated with increased incidence of cancer and cardiovascular disease, but a very large, randomised, placebo‐controlled trial of supplementation with vitamin D (cholecalciferol) did not result in a lower incidence of either disease. It has been suggested that other important effects of sunshine such as the photorelease of nitric oxides in the skin may explain the link with reduced cardiovascular disease and similar considerations may apply to the incidence of both cancer and respiratory illness.
During the rainy season in Tropical locations increased humidity reduces evaporation in the respiratory tract and its temperature will be closer to body temperature. When this temperature difference is small any strain that can be transmitted is more likely to infect both the upper and mid (or lower) respiratory tract, causing symptomatic illness.
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were created or analysed in this study.
REFERENCES
- 1. Hope‐Simpson RE. Epidemic mechanisms of type A influenza. J Hyg. 1979;83(1):11‐26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Tamerius J, Nelson MI, Zhou SZ, Viboud C, Miller MA, Alonso WJ. Global influenza seasonality: Reconciling patterns across temperate and tropical regions. Environ Health Perspect. 2011;119(4):439‐445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. du Prel JB, Puppe W, Gröndahl B, et al. Are meteorological parameters associated with acute respiratory tract infections? Clin Infect Dis. 2009;49(6):861‐868. [DOI] [PubMed] [Google Scholar]
- 4. Viegas M, Barrero PR, Maffey AF, Mistchenko AS. Respiratory viruses seasonality in children under five years of age in Buenos Aires, Argentina: A five‐year analysis. J Infect. 2004;49(3):222‐228 [DOI] [PubMed] [Google Scholar]
- 5. Hope‐Simpson RE. The Transmission of Epidemic Influenza. Springer Science & Business Media; 2013. [Google Scholar]
- 6. Moura FE, Nunes IF, Silva GB, Jr. , Siqueria MM. Respiratory syncytial virus infections in North‐Eastern Brazil: Seasonal trends and general aspects. Am J Trop Med Hyg. 2006;74(2):165‐167. [PubMed] [Google Scholar]
- 7. Tang JW, Lai FYL, Wong F, Hon KLE. Incidence of common respiratory viral infections related to climate factors in hospitalized children in Hong Kong. Epidemiol Infect. 2010;138(2):226‐235. [DOI] [PubMed] [Google Scholar]
- 8. Hope‐Simpson RE. The role of season in the epidemiology of influenza. J Hyg. 1981;86(1):35‐47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kormuth KA, Lin K, Prussin AJ, et al. Influenza virus infectivity is retained in aerosols and droplets independent of relative humidity. J Infect Dis. 2018;218(5):739‐747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Karim YG, Ijaz MK, Sattar SA, Johnson‐Lussenberg CM. Effect of relative humidity on the airborne survival of rhinovirus‐14. Can J Microbiol. 1985;31:1058‐1061. [DOI] [PubMed] [Google Scholar]
- 11. Niazi S, Groth R, Cravigan L, et al. Susceptibility of an airborne common cold virus to relative humidity. Environ Sci Technol. 2021;55(1):499‐508. [DOI] [PubMed] [Google Scholar]
- 12. Elazhary MA, Derbyshire JB. Aerosol stability of bovine parainfluenza type 3 virus. Can J Comp Med. 1979;43(3):295‐304. [PMC free article] [PubMed] [Google Scholar]
- 13. Lidwell OM, Morgan RW, Williams REO. The epidemiology of the common cold IV. The effect of weather. J Hyg. 1965;63(3):427‐439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Van Loghem JJ. An epidemiological contribution to the knowledge of the respiratory diseases. J Hyg. 1928;28(1):33‐54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Hajat S, Bird W, Haines A. Cold weather and GP consultations for respiratory conditions by elderly people in 16 locations in the UK. Eur J Epidemiol. 2004;19(10):959‐968. [DOI] [PubMed] [Google Scholar]
- 16. Mecenas P, Travassos da Rosa Moreira Bastos R, Carlos Rosario Vallinoto A, Normando D. Effects of temperature and humidity on the spread of COVID‐19: A systematic review. PLoS One. 2020;18(9):15e0238339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. A Timeline of COVID‐19 Developments in 2020; 2021. https://www.ajmc.com/view/a‐timeline‐of‐covid19‐developments‐in‐2020. Accessed April 14, 2021. [Google Scholar]
- 18. Gu Y. Covid‐19‐Projections; 2021. https://covid19‐projections.com. Accessed April 14, 2021. [Google Scholar]
- 19. National Climate Report; 2021. https://www.ncdc.noaa.gov/sotc/national/202009. Accessed April 14, 2021. [Google Scholar]
- 20. Paynter S, Ware RS, Sly PD, Williams G, Weinstein P. Seasonal immune modulation in humans: Observed patterns and potential environmental drivers. J Infect. 2015;70(1):1‐10. [DOI] [PubMed] [Google Scholar]
- 21. Milam DF, Smillie WG. A bacteriological study of “Colds” on an isolated tropical island St. John, United States Virgin Islands, West Indies. J Exp Med. 1931;53(5):733‐752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Andrewes CH. Adventures among viruses. III. The puzzle of the common cold. Clin Infect Dis. 1989;11(6):1022‐1028. [DOI] [PubMed] [Google Scholar]
- 23. Dowling HF, Jackson GG, Spiesman IG, Inouye T. Transmission of the common cold to volunteers under controlled conditions. Am J Hyg. 1958;68(1):59‐65. [DOI] [PubMed] [Google Scholar]
- 24. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007;85(3):860‐868. [DOI] [PubMed] [Google Scholar]
- 25. Manson JE, Cook NR, Lee I‐M, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33‐44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Weller RB. Beneficial effects of sunlight may account for the correlation between serum vitamin D levels and cardiovascular health. JAMA Cardiol 2020;5:109. [DOI] [PubMed] [Google Scholar]
- 27. Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect. 1998;121(1):121‐128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Shaw Stewart PD. Seasonality and selective trends in viral acute respiratory tract infections. Med Hypotheses. 2016;86(86):104‐119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Ansart S, Pelat C, Boelle P‐Y, Carrat F, Flahault A, Valleron A‐J. Mortality burden of the 1918‐1919 influenza pandemic in Europe. 2009;3(3):99‐106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Bendix A. India's sudden drop in coronavirus cases has puzzled disease experts. Strict Public Health Measures and Difficulty Recording Rural Cases may have Factored in. 2021. https://www.businessinsider.com/india‐decline‐coronavirus‐cases‐deaths‐what‐happened‐2021‐2 [Google Scholar]
- 31. Nguyen M, Martinez L. LA's COVID Cases, Deaths Decrease ‘Significantly’; 2021. https://laist.com/latest/post/20210201/LA‐covid‐cases‐deaths‐decrease‐significantly. Accessed April 14, 2021. [Google Scholar]
- 32.Weekly Epidemiological Update‐2 February 2021 World Health Organization (WHO), 2021. [Google Scholar]
- 33. Lwoff A. Factors influencing the evolution of viral diseases at the cellular level and in the organism. Bacteriol Rev. 1959;23(3):109‐124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Richman DD, Murphy BR. The association of the temperature‐sensitive phenotype with viral attenuation in animals and humans: Implications for the development and use of live virus vaccines. Clin Infect Dis. 1979;1(3):413‐433. [DOI] [PubMed] [Google Scholar]
- 35. Eccles R. Why is temperature sensitivity important for the success of common respiratory viruses? Rev Med Virol. 2020;10:e02153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Viral hemorragic fever; 2020. https://en.wikipedia.org/wiki/Viral_hemorrhagic_fever. Accessed April 14, 2021. [Google Scholar]
- 37. Cressler CE, McLeod DV, Rozins C, Van Den Hoogen J, Day T. The adaptive evolution of virulence: A review of theoretical predictions and empirical tests. Parasitology. 2016;143(7):915‐930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Fenner F, Marshall ID. A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. J Hyg. 1957;55(2):149‐191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Ewald PW. Host‐parasite relations, vectors, and the evolution of disease severity. Annu Rev Ecol Systemat. 1983;14(1):465‐485. [Google Scholar]
- 40. Thompson DC, Barbu MG, Beiu C, et al. The impact of COVID‐19 pandemic on long‐term care facilities worldwide: An overview on international issues. Biomed Res Int. 2020;2020:8870249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Price WH. The isolation of a new virus associated with respiratory clinical disease in humans. Proc Natl Acad Sci. 1956;42(12):892‐896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Tyrrell DAJ, Parsons R. Some virus isolations from common colds. Lancet. 1960;275:239‐242. [DOI] [PubMed] [Google Scholar]
- 43. Bradburne AF, Bynoe ML, Tyrrell DA. Effects of a “new” human respiratory virus in volunteers. Br Med J. 1967;3(5568):767‐769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Stern H, Tippett KC. Primary isolation of influenza viruses at 33°C. Lancet. 1963;281(7294):1301‐1302. [DOI] [PubMed] [Google Scholar]
- 45. Kung HC, Jen KF, Yuan WC, Tien SF, Chu CM. Influenza in China in 1977: recurrence of influenza A subtype H1N1. Bull World Health Organ. 1987;56(6):913. [PMC free article] [PubMed] [Google Scholar]
- 46. Oxford JS, Corcoran T, Schild GC. Naturally occurring temperature‐sensitive influenza A viruses of the H1N1 and H3N2 subtypes. J General Virol. 1980;48(2):383‐389. [DOI] [PubMed] [Google Scholar]
- 47. Jardon M, Garnier A. pH, pCO2, and temperature effect on R‐adenovirus production. Biotechnol Prog. 2003;19(1):202‐208. [DOI] [PubMed] [Google Scholar]
- 48. Sato K, Watanabe O, Ohmiya S, et al. Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect. Microbiol Immunol. 2016;60(11):801‐805. [DOI] [PubMed] [Google Scholar]
- 49. Sato K, Watanabe O, Ohmiya S, et al. Efficient isolation of human metapneumovirus using MNT‐1, a human malignant melanoma cell line with early and distinct cytopathic effects. Microbiol Immunol. 2017;61(11):497‐506. [DOI] [PubMed] [Google Scholar]
- 50. Massin P, Kuntz‐Simon G, Barbezange C, et al. Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells. Vet Microbiol. 2010;142(3–4):232‐241. [DOI] [PubMed] [Google Scholar]
- 51. Chu CM, Tian SF, Ren GF, Zhang YM, Zhang LX, Liu GQ. Occurrence of temperature‐sensitive influenza A viruses in nature. J Virol. 1982;41(2):353‐359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Frielle DW, Huang DD, Youngner JS. Persistent infection with influenza A virus: Evolution of virus mutants. Virology. 1984;138(1):103‐117. [DOI] [PubMed] [Google Scholar]
- 53. Liu B, Hossain MJ, Mori I, Kimura Y. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live‐attenuated vaccine candidate in the mouse model. J Med Virol. 2008;80(5):888‐894. [DOI] [PubMed] [Google Scholar]
- 54. Hope‐Simpson RE, Golubev DB. A new concept of the epidemic process of influenza A virus. Epidemiol Infect. 1987;99(1):5‐54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Preble OT, Youngner JS. Temperature‐sensitive viruses and the etiology of chronic and inapparent infections. J Infect Dis. 1975;131(4):467‐473. [DOI] [PubMed] [Google Scholar]
- 56. Gebauer F, de la Torre JC, Gomes I, et al. Rapid selection of genetic and antigenic variants of foot‐and‐mouth disease virus during persistence in cattle. J Virol. 1988;62(6):2041‐2049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Russell PH. Newcastle disease virus and two influenza viruses: differing effects of acid and temperature on the uptake of infectious virus into bovine and canine kidney cell lines. Arch Virol. 1986;88(3–4):159‐166. [DOI] [PubMed] [Google Scholar]
- 58. Fei Y, Sun Y‐S, Li Y, et al. Characterization of receptor binding profiles of influenza A viruses using an ellipsometry‐based label‐free glycan microarray assay platform. Biomolecules. 2015;5:1480‐1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Takashita E, Muraki Y, Sugawara K, et al. Intrinsic temperature sensitivity of influenza C virus hemagglutinin‐esterase‐fusion protein. J Virol. 2012;86(23):13108‐13111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Plotch SJ, Krug RM. Influenza virion transcriptase: Synthesis in vitro of large, polyadenylic acid‐containing complementary RNA. J Virol. 1977;21(1):24‐34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Muraki Y, Hongo S. The molecular virology and reverse genetics of influenza C virus. Jpn J Infect Dis. 2010;63(3):157‐165. [PubMed] [Google Scholar]
- 62. Nagele A, Meier‐Ewert H. Influenza‐C‐virion‐associated RNA‐dependent RNA‐polymerase activity. Biosci Rep. 1984;4:703‐706. [DOI] [PubMed] [Google Scholar]
- 63. Ulmanen I, Broni B, Krug RM. Influenza virus temperature‐sensitive cap (m7GpppNm)‐dependent endonuclease. J Virol. 1983;45(1):27‐35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Kashiwagi T, Hara K, Nakazono Y, Hamada N, Watanabe H. Artificial hybrids of influenza A virus RNA polymerase reveal PA subunit modulates its thermal sensitivity. PLoS One. 2010;5(12): e15140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Ngai KL, Chan MC, Chan PK. Replication and transcription activities of ribonucleoprotein complexes reconstituted from avian H5N1, H1N1pdm09 and H3N2 influenza viruses. PLoS One. 2013;8(6):e65038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Dalton RM, Mullin AE, Amorim JJ, Medcalf E, Tiley LS, Digard P. Temperature sensitive influenza A virus genome replication results from low thermal stability of polymerase‐cRNA complexes. Virology. 2006;3(1):58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Chursov A, Kopetzky SJ, Leshchiner I, Kondofersky I, Theis FJ, Frishman D. Specific temperature‐induced perturbations of secondary nRNA structures are associated with the cold‐adapted temperature‐sensitive phenotype of influenza A virus. RNA Biol. 2012;9(10):1266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Baranovskaya IL, Sergeeva MV, Taraskin AS, Lozhkov AA, Vasin AV. Mutations designed to modify the NS gene mRNA secondary structure affect influenza A pathogenicity in vivo. MIR J. 2021;8(1):1‐9. [Google Scholar]
- 69. Narberhaus F, Waldminghaus T, Chowdhury S. RNA thermometers. FEMS (Fed Eur Microbiol Soc) Microbiol Rev. 2006;30(1):3‐16. [DOI] [PubMed] [Google Scholar]
- 70. McFadden ER, Jr. , Pichurko BM, Bowman HF, et al. Thermal mapping of the airways in humans. J Appl Physiol. 1985;58(2):564‐570. [DOI] [PubMed] [Google Scholar]
- 71. Influenza virus vaccine live intranasal‐‐‐MedImmune vaccines: CAIV‐T, influenza live intranasal. Drugs R D 2003;4(5):312‐319. [DOI] [PubMed] [Google Scholar]
- 72. Shachor‐Meyouhas Y, Kasses I. Petechial rash with pandemic influenza (H1N1) infection. Pediatr Infect Dis J. 2010;29(5):480. [DOI] [PubMed] [Google Scholar]
- 73. Vano‐Galvan S, Martorell A. Chilblains. Can Med Assoc J. 2012;184(1):67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Massey PR, Jones KM. Going viral: a brief history of Chilblain‐like skin lesions (“COVID toes”) amidst the COVID‐19 pandemic. Seminars Oncol. 2020;47(5):330‐334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. McGonagle D, Bridgewood C, Ramanan AV, Meaney JF, Watad A. COVID‐19 vasculitis and novel vasulitis mimics. Lancet Rheumatol. 2021;3(3):e224‐e233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Evans SS, Repasky EA DTF. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15(6):335‐349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Schulman CI, Namias N, Doherty J, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect. 2005;6(4):369‐375. [DOI] [PubMed] [Google Scholar]
- 78. Thai PQ, Welkers MR, Hang NL, et al. Pandemic H1N1 virus transmission and shedding dynamics in index case housholds of a prospective Vietnamese cohort. J Infect. 2014;68(6):581‐590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Foy HM, Cooney MK, Allan ID, Albrecht JK. Influenza B in households: virus shedding without symptoms or antibody response. Am J Epidemiol. 1987;126(3):506‐515. [DOI] [PubMed] [Google Scholar]
- 80. Papenburg J, Baz M, Hamelin ME, et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidnce of asymptomatic infections. Clin Infect Dis. 2010;51(9):1033‐1041. [DOI] [PubMed] [Google Scholar]
- 81. Tandale BV, Pawar SD, Burav YK, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. Br Med J Infect Dis. 2010;10(1):255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Granados A, Goodall EC, Luinstra LK, Smieja M, Mahony J. Comparison of asymptomatic and symptomatic rhinovirus infections in university students: incidence, species diversity, and viral load. Diagnostic Microbiol Infect Dis. 2015;82(4):292‐296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Shaman J, Galanti M. Direct observation of repeated infections with endemic coronaviruses. J Infect Dis. 2021;223(3):409‐415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Galanti M, Birger R, Ud‐Dean M, et al. Longitudinal active sampling for respiratory viral infections across age groups. Influenza Other Respir Viruses. 2019;13(3):226‐232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Galanti M, Birger R, Ud‐Dean M, et al. Rates of asymptomatic respiratory virus infection across age groups. Epidemiol Infect. 2019;147(e176):1‐6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Allen TR, Bradburne AF, Stott EJ, Goodwin CS, Tyrell DAJ. An outbreak of common colds at an Antarctic base after seventeen weeks of complete isolation. J Hyg. 1973;71(4):657‐667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Cameron AS, Moore BW. The epidemiology of respiratory infection in an isolated Antarctic community. J Hyg. 1968;66(3):427‐437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Muchmore HG, Parkinson AJ, Humphries JE, Scott EN, McIntosh DA, Scott LV. Persistent parainfluenza virus shedding during isolation at the South Pole. Nature. 1981;289:187‐189. [DOI] [PubMed] [Google Scholar]
- 89. Mudd S, Grant SB. Reactions to chilling of the body surface: experimental study of a possible mechanism for the excitation of infections of the pharynx and tonsils. J Med Res. 1919;40(1):53. [PMC free article] [PubMed] [Google Scholar]
- 90. Donaldson GC, Keatinge WR, Bucher K. Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. Lancet. 1997;349(9092):1341‐1346. [PubMed] [Google Scholar]
- 91. Douglas RG, Jr. , Lindgren KM, Couch RB. Exposure to cold environment and rhinovirus common cold: failure to demonstrate effect. N. Engl J Med. 1968;279(14):742‐747. [Google Scholar]
- 92. Girardi AJ, Jensen FC, Koprowski H. SV40‐induced transformation of human diploid cells: crisis and recovery. J Cell Comp Physiol. 1965;65(1):69‐83. [DOI] [PubMed] [Google Scholar]
- 93. Coronavirus (COVID‐19) Cases. 2021. https://ourworldindata.org/covid‐cases?country=IND∼USA∼GBR∼CAN∼DEU∼FRA [Google Scholar]
- 94. Byambasuren O, Cardona M, Bell K, Clark J, McLaws ML, Glasziou P. Estimating the extent of true asymptomatic COVID‐19 and its potential for community transmission: systematic review and meta‐analysis. 2020;23. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3586675 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Zaitchik BF, Sweijd N, Shumake‐Guillemot J, et al. A framework for research linking weather, climate and COVID‐19. Nat Commun. 2020;11(1):1‐3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Pan J, Yao Y, Liu Z, et al. Warmer weather unlikely to reduce the COVID‐19 transmission: An ecological study in 202 locations in 8 countries. Sci Total Environ. 2021;753:142272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Guo C, Bo Y, Lin C, et al. Meteorological factors and COVID‐19 incidence in 190 countries: an observational study. Sci Total Environ. 2021;25(757):143783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Ward M, Xiao S, Zhang Z. Humidity is a consistent climactic factor contributing to SARS‐CoV‐2 transmission. Transboundary and Emerging Diseases. 2020;67:3069‐3074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Jamshidi S, Baniasad M, Niyogi D. Global to USA county scale analysis of weather, urban density, mobility, homestay and mask use on COVID‐19. Int J Environ Res Public Health. 2020;17(21). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Scholtissek C, Rott R. Effect of temperature on the multiplication of an influenza virus. J General Virol. 1969;5(2):283‐290. [DOI] [PubMed] [Google Scholar]
- 101. Johnson C, Eccles R. Acute cooling of the feet and the onset of common cold symptoms. Fam Pract. 2005;22(6):608‐613. [DOI] [PubMed] [Google Scholar]
- 102. Bedford T, Riley S, Barr IG, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015;523(7559):217‐220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103. Harper GJ. Airborne micro‐organisms: survival tests with four viruses. Epidemiol Infect. 1961;59(4):479‐486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Songer JR. Influence of relative humidity on the survival of some airborne viruses. Appl Microbiol. 1967;15(1):35‐42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Akers TG, Hatch MT. Survival of a picornavirus and its infectious ribonucleic acid after aerosolization. Epidemiol Infect. 1973;71(2):325‐339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106. Hugh‐Jones M, Allan WH, Dark FA, Harper GJ. The evidence for the airborne spread of Newcastle disease. J Hyg. 1973;71(2):325‐339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Schaffer FL, Soergel ME, Straube DC. Survival of airborne influenza virus: effects of propogating host, relative humidity, and composition of spray fluids. Arch Virol. 1976;51(4):263‐273. [DOI] [PubMed] [Google Scholar]
- 108. Elazhary MA, Derbyshire JB. Effect of termperature, relative humidity and medium on the aerosol stability of infectious bovine rhinotracheitis virus. Can J Comp Med. 1979;43(2):158. [PMC free article] [PubMed] [Google Scholar]
- 109. Elazhary MA, Derbyshire JB. Aerosol stability of bovine adenovirus type 3. Can J Comp Med. 1979;43(3):305‐312. [PMC free article] [PubMed] [Google Scholar]
- 110. Ijaz MK, Brunner AH, Sattar SA, Nair RC, Johnson‐Lussenberg CM. Survival characteristics of airborne human coronavirus 229E. J General Virol. 1985;66(12):2743‐2748. [DOI] [PubMed] [Google Scholar]
- 111. Schoenbaum MA, Zimmerman JJ, Beran GW, Murphy DP. Survival of pseudorabies virus in aerosol. Am J Vet Res. 1990;51(3):331‐333. [PubMed] [Google Scholar]
- 112. Schuit M, Ratnesar‐Shumate S, Yolitz J, et al. Airborne SARS‐CoV‐2 is rapidly inactivated by simulated sunlight. J Infect Dis. 2020;222(4):564‐571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Jackson GG, Dowling HF, Anderson TO, Riff L, Saporta J, Turck M. Susceptibility and immunity to common upper respiratory viral infections‐‐‐the common cold. Ann Intern Med. 1960;53(4):719‐738. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article as no new data were created or analysed in this study.